Logo image of CTM

CASTELLUM INC (CTM) Stock Fundamental Analysis

USA - NYSEARCA:CTM - US14838T2042 - Common Stock

0.9825 USD
-0.07 (-6.43%)
Last: 10/10/2025, 9:19:23 PM
0.97 USD
-0.01 (-1.27%)
After Hours: 10/10/2025, 9:19:23 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CTM. CTM was compared to 86 industry peers in the IT Services industry. CTM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTM has reported negative net income.
CTM had a negative operating cash flow in the past year.
CTM had negative earnings in each of the past 5 years.
In multiple years CTM reported negative operating cash flow during the last 5 years.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

CTM has a Return On Assets of -12.95%. This is amonst the worse of the industry: CTM underperforms 80.23% of its industry peers.
The Return On Equity of CTM (-17.71%) is worse than 68.60% of its industry peers.
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROIC N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CTM has a Gross Margin (39.27%) which is comparable to the rest of the industry.
CTM's Gross Margin has declined in the last couple of years.
CTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTM has more shares outstanding
Compared to 1 year ago, CTM has an improved debt to assets ratio.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 4.46 indicates that CTM is not in any danger for bankruptcy at the moment.
CTM has a Altman-Z score of 4.46. This is in the better half of the industry: CTM outperforms 67.44% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CTM is not too dependend on debt financing.
The Debt to Equity ratio of CTM (0.13) is better than 66.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 4.46
ROIC/WACCN/A
WACC8.51%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 3.62 indicates that CTM has no problem at all paying its short term obligations.
CTM's Current ratio of 3.62 is amongst the best of the industry. CTM outperforms 84.88% of its industry peers.
CTM has a Quick Ratio of 3.62. This indicates that CTM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.62, CTM belongs to the best of the industry, outperforming 84.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.62
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.63% over the past year.
Looking at the last year, CTM shows a small growth in Revenue. The Revenue has grown by 4.17% in the last year.
The Revenue has been growing by 21.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%

3.2 Future

Based on estimates for the next years, CTM will show a very strong growth in Earnings Per Share. The EPS will grow by 45.77% on average per year.
The Revenue is expected to decrease by -1.20% on average over the next years.
EPS Next Y112.5%
EPS Next 2Y45.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.86%
Revenue Next 2Y-1.2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -0.05 -0.1 -0.15 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 97.28, CTM can be considered very expensive at the moment.
CTM's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.57. CTM is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 97.28
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTM's earnings are expected to grow with 45.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTELLUM INC

NYSEARCA:CTM (10/10/2025, 9:19:23 PM)

After market: 0.97 -0.01 (-1.27%)

0.9825

-0.07 (-6.43%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-08 2025-08-08/amc
Earnings (Next)11-11 2025-11-11
Inst Owners7.51%
Inst Owner Change0%
Ins Owners9.49%
Ins Owner Change-15.32%
Market Cap91.37M
Analysts80
Price Target3.06 (211.45%)
Short Float %2.36%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 97.28
P/S 1.92
P/FCF N/A
P/OCF N/A
P/B 2.88
P/tB 6.09
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.01
Fwd EY1.03%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.51
BVpS0.34
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.27%
FCFM N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.57%
Cap/Sales 0.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.62
Altman-Z 4.46
F-Score4
WACC8.51%
ROIC/WACCN/A
Cap/Depr(3y)1.76%
Cap/Depr(5y)1.22%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
EPS Next Y112.5%
EPS Next 2Y45.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%
Revenue Next Year-5.86%
Revenue Next 2Y-1.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.46%
OCF growth 3YN/A
OCF growth 5YN/A